We are live on ! Find out more
HR

Howe & Rusling Portfolio holdings

AUM $1.53B
1-Year Est. Return 21.45%
This Fund
S&P 500
This Quarter Est. Return
-10.75%
1 Year Est. Return
+21.45%
3 Year Est. Return
+66.11%
5 Year Est. Return
+83.74%
10 Year Est. Return
+259.21%
AUM
$789M
AUM Growth
-$76.5M
Cap. Flow
+$29.9M
Cap. Flow %
3.79%
Top 10 Hldgs %
27.06%
Holding
1,208
New
169
Increased
297
Reduced
314
Closed
91

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$9.36M
2
TSN icon
Tyson Foods
TSN
+$4.6M
3
BAC icon
Bank of America
BAC
+$4.41M
4
HAS icon
Hasbro
HAS
+$3.88M
5
USB icon
US Bancorp
USB
+$3.09M

Sector Composition

Rank Sector Weight
1 Technology 13.04%
2 Healthcare 12.98%
3 Financials 11.5%
4 Consumer Staples 8.7%
5 Industrials 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCO icon
151
Brink's
BCO
$4.77B
$319K 0.04%
5,249
+68
+1% +$4.09K
DOL icon
152
WisdomTree True Developed International Fund
DOL
$841M
$317K 0.04%
7,569
+900
+13% +$41.3K
IXUS icon
153
iShares Core MSCI Total International Stock ETF
IXUS
$59.7B
$316K 0.04%
5,544
+195
+4% +$12K
REGL icon
154
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.81B
$311K 0.04%
4,606
+284
+7% +$19.9K
XEL icon
155
Xcel Energy
XEL
$48.2B
$308K 0.04%
4,347
+3,222
+286% +$234K
NFLX icon
156
Netflix
NFLX
$309B
$301K 0.04%
17,200
+12,360
+255% +$274K
DORM icon
157
Dorman Products
DORM
$4.23B
$299K 0.04%
2,725
KAMN
158
DELISTED
Kaman Corp
KAMN
$298K 0.04%
9,529
SHY icon
159
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
$296K 0.04%
3,572
SCL icon
160
Stepan Co
SCL
$1.46B
$295K 0.04%
2,909
GILD icon
161
Gilead Sciences
GILD
$164B
$294K 0.04%
4,762
+165
+4% +$10.2K
IWN icon
162
iShares Russell 2000 Value ETF
IWN
$14.6B
$290K 0.04%
2,133
-25
-1% -$3.72K
CL icon
163
Colgate-Palmolive
CL
$74.4B
$288K 0.04%
3,589
+1,908
+114% +$149K
BAX icon
164
Baxter International
BAX
$14.1B
$284K 0.04%
4,426
-27
-0.6% -$1.96K
TKR icon
165
Timken Company
TKR
$9.13B
$283K 0.04%
5,330
-7
-0.1% -$409
CVS icon
166
CVS Health
CVS
$126B
$277K 0.04%
2,988
+7
+0.2% +$683
EMR icon
167
Emerson Electric
EMR
$91B
$275K 0.03%
3,459
+29
+0.8% +$2.56K
SCHX icon
168
Schwab US Large- Cap ETF
SCHX
$74.1B
$275K 0.03%
18,486
+594
+3% +$9.63K
FNDX icon
169
Schwab Fundamental US Large Company Index ETF
FNDX
$27.2B
$272K 0.03%
16,023
+1,869
+13% +$34.4K
EPAC icon
170
Enerpac Tool Group
EPAC
$1.89B
$270K 0.03%
14,185
+1,259
+10% +$25.4K
IJS icon
171
iShares S&P Small-Cap 600 Value ETF
IJS
$8.32B
$268K 0.03%
3,007
MUSA icon
172
Murphy USA
MUSA
$10.7B
$267K 0.03%
1,148
REGN icon
173
Regeneron Pharmaceuticals
REGN
$79.1B
$259K 0.03%
438
UNVR
174
DELISTED
Univar Solutions Inc.
UNVR
$258K 0.03%
10,370
FGD icon
175
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.58B
$257K 0.03%
11,840
-17,609
-60% -$423K

Similar funds

Howe & Rusling's Q2 2022 Portfolio in Review

As of Q2 2022, Howe & Rusling held 1,208 positions worth $789M, down 8.8% from $865M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Howe & Rusling deployed $29.9M of net new capital in Q2 2022, opening 169 new positions and adding to 297 existing holdings. Its largest new stake was AstraZeneca: 35,197 shares worth $4.65M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $9.36M trimmed.

  • Howe & Rusling's largest Q2 2022 buy was AstraZeneca: 35,197 shares worth $4.65M.
  • Howe & Rusling added most to Lowe's Companies in Q2 2022, an estimated $6.75M increase.
  • Howe & Rusling's biggest Q2 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $9.36M.
  • Howe & Rusling fully exited Traeger in Q2 2022, selling an estimated $124K.
  • Howe & Rusling's ten largest holdings make up 27% of its $789M portfolio in Q2 2022.
  • Howe & Rusling opened 169 new positions and closed 91 in Q2 2022.
  • Howe & Rusling's portfolio value fell 8.8% quarter-over-quarter to $789M.

Based on Howe & Rusling's 13F filing for Q2 2022, filed 15 Aug 2022.